Prostate cancer screening.

Prostate cancer is a common cancer and a leading cause of cancer death in men. It is potentially detectable at early, possibly curative stages through various combinations of testing, including DRE, PSA, and TRUS of the prostate. Still unproven is the effectiveness of prostate cancer treatment, and because of that lack of proof, the optimal screening strategies are also elusive. It is possible that what is known as prostate cancer today may be, in fact, multiple entities with different natural histories, different treatment needs, and, consequently, different screening strategies. The role of informed consent has been suggested as a means to involve patients in the decision process, especially because the literature presents an environment of intense controversy. It is hoped that the PIVOT trial or similar efforts and further research into the basic mechanisms of the disease will provide clearer answers in the future.

Screening guidelines in a family medicine program: a five-year experience.

An audit of charts of 112 adult patients at the University of Rochester Family Medicine Program was conducted to determine the effect of screening guidelines introduced into the practice in 1975. Beyond the initial educational effort when the guidelines were introduced and a verbal explanation of the guidelines printed in each patient record given to new providers as they entered the program, no continuous encouragement was offered. Over the next five years, provider compliance fell short of the guideline recommendations for all 10 screening tests. Depending on the test, 10 to 100 percent of patients received no screening over that period. Tests performed by nursing personnel were completed more frequently than those performed by physicians (P=0.05). Frequency of screening by physicians correlated with the frequency of complete physical examination (P less than 0.0001) and sex (P less than 0.02), and screening by nurses correlated with complete physical examination frequency (P less than 0.0001), visit rate (P less than 0.0001), and patient age (P less than 0.0001). Awareness of screening recommendations was insufficient to result in provider compliance with them. Strategies for improving screening compliance are discussed.

Gaining strategic advantages through partnerships with public health departments.

Public health officials have advocated in public health and public policy journals for collaboration with private sector health care organizations for nearly a decade. There has been little written in the management literature on this topic, however. There are several important areas in which public health departments have expertise that could be valuable to private sector health care organizations, including health maintenance organizations (HMOs). These include the delivery of services in some geographic areas and to some special populations, provision of preventive and health promotion services to HMO members, performance of epidemiology services, assistance in accreditation, and repair of the damaged image of HMOs. HMOs and local health departments in many parts of the country are already entering into contracts for these purposes. Such partnerships between HMOs and local health departments can improve the health of the members of HMO plans and contribute to improving the health of the community.